University of Queensland PhD student Hemanshi Galaiya has been named a 2025 Universitas 21 Leader of the Future, recognised for her work expanding access to STEM education for under-resourced students in Kenya.
Researchers at the University of Queensland’s Australian Institute for Bioengineering and Nanotechnology are working to develop a vaccine in just 100 days to support future pandemic preparedness.
AIBN researchers have secured a major grant to position lignin as a key plank in the $15 billion market for sustainable rubbers, adhesives, and coatings.
With the support of the Lily Foundation, University of Cambridge Neurologist Dr Jelle van den Ameele and AIBN group leader Dr Seth Cheetham are hoping to change the fortunes of those born with a fatal condition.
A new facility at the Australian Institute for Bioengineering and Nanotechnology is set to provide researchers with cancer vaccines tailored to individual patients.